{"transactions":[{"id":2702655,"issuer":{"id":8208,"kind":"organization","name":"Hepion Pharmaceuticals, Inc.","symbol":"HEPA"},"owners":[{"id":139178,"kind":"person","name":"Lippa Arnold","position":1,"cik":"0001363763","reported_name":"Lippa Arnold","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Options","published_at":"2021-05-20T19:12:44.000Z","date":"2021-05-18","kind":"grant","acquired":true,"shares":200000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Stock Options have been granted subject to stockholder approval of an increase in the shares of common stock issuable pursuant to the 2013 Equity Incentive Plan."}],"balance_after":291110,"derivative":{"exercise_price":1.7,"exercise_date":"2022-05-18","expiration_date":"2031-05-18","underlying":"Common Stock","underlying_shares":200000},"source":{"system":"sec-edgar","filing":"0001104659-21-070074","document":"tm2117144-7_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1363763/000110465921070074/tm2117144-7_4seq1.xml","form_type":"4"}},{"id":3017401,"issuer":{"id":146118,"kind":"organization","name":"RespireRx Pharmaceuticals Inc.","symbol":"RSPI"},"owners":[{"id":139178,"kind":"person","name":"Lippa Arnold","position":1,"cik":"0001363763","reported_name":"Lippa Arnold","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Exec. Chairman & CSO"}}],"security":"Series H Preferred Stock","published_at":"2020-10-02T15:47:42.000Z","date":"2020-09-30","kind":"gift","acquired":true,"shares":100,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"By Trust"},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"The full designation of this class of preferred stock is \"Series H 2% Voting, Non-Participating, Convertible Preferred Stock\"."},{"field":"kind","element":"transactionCoding","label":"F4","text":"The disposition or acquisition, as applicable, reflects an estate planning transaction."},{"field":"derivative.underlying","element":"underlyingSecurityTitle","label":"F3","text":"Each Conversion Unit consists of one share of the common stock of the Company, and one warrant exercisable into one share of the common stock of the Company (such warrant having an initial exercise price of $0.007 per share, and terminating on September 30, 2023)."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F5","text":"Dr. Lippa gifted these securities into a family trust for the benefit of his spouse, daughter and grandchildren. Dr. Lippa is not the trustee, does not exercise voting or investment control over shares held in the trust, and disclaims beneficial ownership of the shares of Series H Preferred Stock owned by the trust, except to the extent of his pecuniary interest therein."}],"balance_after":0,"derivative":{"exercise_price":0.0064,"exercise_date":"2020-09-30","expiration_date":"2023-09-30","underlying":"Conversion Units","underlying_shares":15625000},"source":{"system":"sec-edgar","filing":"0001493152-20-018819","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/849636/000149315220018819/ownership.xml","form_type":"4"}},{"id":3017400,"issuer":{"id":146118,"kind":"organization","name":"RespireRx Pharmaceuticals Inc.","symbol":"RSPI"},"owners":[{"id":139178,"kind":"person","name":"Lippa Arnold","position":1,"cik":"0001363763","reported_name":"Lippa Arnold","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Exec. Chairman & CSO"}}],"security":"Series H Preferred Stock","published_at":"2020-10-02T15:47:42.000Z","date":"2020-09-30","kind":"gift","acquired":false,"shares":100,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"The full designation of this class of preferred stock is \"Series H 2% Voting, Non-Participating, Convertible Preferred Stock\"."},{"field":"kind","element":"transactionCoding","label":"F4","text":"The disposition or acquisition, as applicable, reflects an estate planning transaction."},{"field":"derivative.underlying","element":"underlyingSecurityTitle","label":"F3","text":"Each Conversion Unit consists of one share of the common stock of the Company, and one warrant exercisable into one share of the common stock of the Company (such warrant having an initial exercise price of $0.007 per share, and terminating on September 30, 2023)."}],"balance_after":0,"derivative":{"exercise_price":0.0064,"exercise_date":"2020-09-30","expiration_date":"2023-09-30","underlying":"Conversion Units","underlying_shares":15625000},"source":{"system":"sec-edgar","filing":"0001493152-20-018819","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/849636/000149315220018819/ownership.xml","form_type":"4"}},{"id":3017399,"issuer":{"id":146118,"kind":"organization","name":"RespireRx Pharmaceuticals Inc.","symbol":"RSPI"},"owners":[{"id":139178,"kind":"person","name":"Lippa Arnold","position":1,"cik":"0001363763","reported_name":"Lippa Arnold","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Exec. Chairman & CSO"}}],"security":"Series H Preferred Stock","published_at":"2020-10-02T15:47:42.000Z","date":"2020-09-30","kind":"other","acquired":true,"shares":100,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"The full designation of this class of preferred stock is \"Series H 2% Voting, Non-Participating, Convertible Preferred Stock\"."},{"field":"kind","element":"transactionCoding","label":"F2","text":"On September 30, 2020, Dr. Lippa agreed to forgive a portion of accrued compensation owing from RespireRx Pharmaceuticals Inc. (the \"Company\") equal to $100,000, and in exchange, the Company issued to Dr. Lippa 100 shares of the Company's Series H 2% Voting, Non-Participating, Convertible Preferred Stock, which equates to a per share value of $1,000.00 per share."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"On September 30, 2020, Dr. Lippa agreed to forgive a portion of accrued compensation owing from RespireRx Pharmaceuticals Inc. (the \"Company\") equal to $100,000, and in exchange, the Company issued to Dr. Lippa 100 shares of the Company's Series H 2% Voting, Non-Participating, Convertible Preferred Stock, which equates to a per share value of $1,000.00 per share."},{"field":"derivative.underlying","element":"underlyingSecurityTitle","label":"F3","text":"Each Conversion Unit consists of one share of the common stock of the Company, and one warrant exercisable into one share of the common stock of the Company (such warrant having an initial exercise price of $0.007 per share, and terminating on September 30, 2023)."}],"balance_after":100,"derivative":{"exercise_price":0.0064,"exercise_date":"2020-09-30","expiration_date":"2023-09-30","underlying":"Conversion Units","underlying_shares":15625000},"source":{"system":"sec-edgar","filing":"0001493152-20-018819","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/849636/000149315220018819/ownership.xml","form_type":"4"}},{"id":3049696,"issuer":{"id":8208,"kind":"organization","name":"Hepion Pharmaceuticals, Inc.","symbol":"HEPA"},"owners":[{"id":139178,"kind":"person","name":"Lippa Arnold","position":1,"cik":"0001363763","reported_name":"Lippa Arnold","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Options","published_at":"2020-08-21T16:17:43.000Z","date":"2020-08-19","kind":"grant","acquired":true,"shares":30000,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":91110,"derivative":{"exercise_price":3.72,"exercise_date":"2021-08-19","expiration_date":"2030-08-19","underlying":"Common Stock","underlying_shares":30000},"source":{"system":"sec-edgar","filing":"0001104659-20-097600","document":"a4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1363763/000110465920097600/a4.xml","form_type":"4"}},{"id":3083064,"issuer":{"id":146118,"kind":"organization","name":"RespireRx Pharmaceuticals Inc.","symbol":"RSPI"},"owners":[{"id":139178,"kind":"person","name":"Lippa Arnold","position":1,"cik":"0001363763","reported_name":"Lippa Arnold","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Exec. Chairman, CEO & CSO"}}],"security":"Series H Preferred Stock","published_at":"2020-07-15T21:14:05.000Z","date":"2020-07-13","kind":"gift","acquired":true,"shares":600,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"By Trust"},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"The full designation of this class of preferred stock is \"Series H 2% Voting, Non-Participating, Convertible Preferred Stock\"."},{"field":"kind","element":"transactionCoding","label":"F4","text":"The disposition or acquisition, as applicable, reflects an estate planning transaction."},{"field":"derivative.underlying","element":"underlyingSecurityTitle","label":"F3","text":"Each Conversion Unit consists of one share of the common stock of the Company, and one warrant exercisable into one share of the common stock of the Company (such warrant having an initial exercise price of $0.007 per share, and terminating on September 30, 2023)."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F5","text":"Dr. Lippa gifted these securities into a family trust for the benefit of his spouse, daughter and grandchildren. Dr. Lippa is not the trustee, does not exercise voting or investment control over shares held in the trust, and disclaims beneficial ownership of the shares of Series H Preferred Stock owned by the trust, except to the extent of his pecuniary interest therein."}],"balance_after":0,"derivative":{"exercise_price":0.0064,"exercise_date":"2020-07-13","expiration_date":"2023-09-30","underlying":"Conversion Units","underlying_shares":93750000},"source":{"system":"sec-edgar","filing":"0001493152-20-013399","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/849636/000149315220013399/ownership.xml","form_type":"4"}},{"id":3083063,"issuer":{"id":146118,"kind":"organization","name":"RespireRx Pharmaceuticals Inc.","symbol":"RSPI"},"owners":[{"id":139178,"kind":"person","name":"Lippa Arnold","position":1,"cik":"0001363763","reported_name":"Lippa Arnold","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Exec. Chairman, CEO & CSO"}}],"security":"Series H Preferred Stock","published_at":"2020-07-15T21:14:05.000Z","date":"2020-07-13","kind":"gift","acquired":false,"shares":600,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"The full designation of this class of preferred stock is \"Series H 2% Voting, Non-Participating, Convertible Preferred Stock\"."},{"field":"kind","element":"transactionCoding","label":"F4","text":"The disposition or acquisition, as applicable, reflects an estate planning transaction."},{"field":"derivative.underlying","element":"underlyingSecurityTitle","label":"F3","text":"Each Conversion Unit consists of one share of the common stock of the Company, and one warrant exercisable into one share of the common stock of the Company (such warrant having an initial exercise price of $0.007 per share, and terminating on September 30, 2023)."}],"balance_after":0,"derivative":{"exercise_price":0.0064,"exercise_date":"2020-07-13","expiration_date":"2023-09-30","underlying":"Conversion Units","underlying_shares":93750000},"source":{"system":"sec-edgar","filing":"0001493152-20-013399","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/849636/000149315220013399/ownership.xml","form_type":"4"}},{"id":3083062,"issuer":{"id":146118,"kind":"organization","name":"RespireRx Pharmaceuticals Inc.","symbol":"RSPI"},"owners":[{"id":139178,"kind":"person","name":"Lippa Arnold","position":1,"cik":"0001363763","reported_name":"Lippa Arnold","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Exec. Chairman, CEO & CSO"}}],"security":"Series H Preferred Stock","published_at":"2020-07-15T21:14:05.000Z","date":"2020-07-13","kind":"other","acquired":true,"shares":600,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"The full designation of this class of preferred stock is \"Series H 2% Voting, Non-Participating, Convertible Preferred Stock\"."},{"field":"kind","element":"transactionCoding","label":"F2","text":"On July 13, 2020, Dr. Lippa agreed to forgive a portion of the accrued but unpaid compensation to which he was entitled pursuant to his employment agreement with RespireRx Pharmaceuticals Inc. (the \"Company\") equal to $600,000. On July 13, 2020, the Company issued to Dr. Lippa 600 shares of the Company's Series H 2% Voting, Non-Participating, Convertible Preferred Stock (\"Series H Preferred Stock\") in exchange for the forgiveness of $600,000 of accrued and unpaid compensation, which equates to a per share value of $1,000.00 per share."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"On July 13, 2020, Dr. Lippa agreed to forgive a portion of the accrued but unpaid compensation to which he was entitled pursuant to his employment agreement with RespireRx Pharmaceuticals Inc. (the \"Company\") equal to $600,000. On July 13, 2020, the Company issued to Dr. Lippa 600 shares of the Company's Series H 2% Voting, Non-Participating, Convertible Preferred Stock (\"Series H Preferred Stock\") in exchange for the forgiveness of $600,000 of accrued and unpaid compensation, which equates to a per share value of $1,000.00 per share."},{"field":"derivative.underlying","element":"underlyingSecurityTitle","label":"F3","text":"Each Conversion Unit consists of one share of the common stock of the Company, and one warrant exercisable into one share of the common stock of the Company (such warrant having an initial exercise price of $0.007 per share, and terminating on September 30, 2023)."}],"balance_after":600,"derivative":{"exercise_price":0.0064,"exercise_date":"2020-07-13","expiration_date":"2023-09-30","underlying":"Conversion Units","underlying_shares":93750000},"source":{"system":"sec-edgar","filing":"0001493152-20-013399","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/849636/000149315220013399/ownership.xml","form_type":"4"}},{"id":3180401,"issuer":{"id":8208,"kind":"organization","name":"Hepion Pharmaceuticals, Inc.","symbol":"HEPA"},"owners":[{"id":139178,"kind":"person","name":"Lippa Arnold","position":1,"cik":"0001363763","reported_name":"Lippa Arnold","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Options","published_at":"2020-04-07T16:14:41.000Z","date":"2020-04-03","kind":"grant","acquired":true,"shares":60000,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":61109,"derivative":{"exercise_price":1.63,"exercise_date":"2021-04-03","expiration_date":"2030-04-03","underlying":"Common Stock","underlying_shares":60000},"source":{"system":"sec-edgar","filing":"0001104659-20-044173","document":"a4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1363763/000110465920044173/a4.xml","form_type":"4"}},{"id":3197168,"issuer":{"id":146118,"kind":"organization","name":"RespireRx Pharmaceuticals Inc.","symbol":"RSPI"},"owners":[{"id":139178,"kind":"person","name":"Lippa Arnold","position":1,"cik":"0001363763","reported_name":"Lippa Arnold","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Exec. Chairman, CEO, CSO"}}],"security":"Common Stock","published_at":"2020-03-24T16:20:37.000Z","date":"2020-03-22","kind":"gift","acquired":false,"shares":4500000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"Dr. Lippa gifted these securities into a family trust for estate planning purposes. He is not the trustee and does not exercise voting or investment control over shares held in the trust, but he is a beneficiary of the trust."}],"balance_after":598,"source":{"system":"sec-edgar","filing":"0001363763-20-000001","document":"primary_doc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/849636/000136376320000001/primary_doc.xml","form_type":"4"}},{"id":3197167,"issuer":{"id":146118,"kind":"organization","name":"RespireRx Pharmaceuticals Inc.","symbol":"RSPI"},"owners":[{"id":139178,"kind":"person","name":"Lippa Arnold","position":1,"cik":"0001363763","reported_name":"Lippa Arnold","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Exec. Chairman, CEO, CSO"}}],"security":"Common Stock","published_at":"2020-03-24T16:20:37.000Z","date":"2020-03-22","kind":"other","acquired":true,"shares":4500000,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"On March 21, 2020, Dr. Lippa agreed to forgive a portion of the accrued but unpaid compensation to which he was entitled pursuant to his employment agreement with RespireRx Pharmaceuticals Inc. (the \"Company\") equal to $153,000.  On March 22, 2020, the Company issued to Dr. Lippa 4,500,000 shares of the Company's common stock, in exchange for the forgiveness of $153,000 of accrued and unpaid compensation, which equates to a per share value of $0.034 per share, the closing share price of the Company's common stock on Friday, March 20, the last business day prior to the transaction."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"On March 21, 2020, Dr. Lippa agreed to forgive a portion of the accrued but unpaid compensation to which he was entitled pursuant to his employment agreement with RespireRx Pharmaceuticals Inc. (the \"Company\") equal to $153,000.  On March 22, 2020, the Company issued to Dr. Lippa 4,500,000 shares of the Company's common stock, in exchange for the forgiveness of $153,000 of accrued and unpaid compensation, which equates to a per share value of $0.034 per share, the closing share price of the Company's common stock on Friday, March 20, the last business day prior to the transaction."}],"balance_after":4500598,"source":{"system":"sec-edgar","filing":"0001363763-20-000001","document":"primary_doc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/849636/000136376320000001/primary_doc.xml","form_type":"4"}},{"id":3455833,"issuer":{"id":8208,"kind":"organization","name":"Hepion Pharmaceuticals, Inc.","symbol":"HEPA"},"owners":[{"id":139178,"kind":"person","name":"Lippa Arnold","position":1,"cik":"0001363763","reported_name":"Lippa Arnold","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Options","published_at":"2019-07-25T16:15:22.000Z","date":"2019-07-24","kind":"grant","acquired":true,"shares":970,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":1109,"derivative":{"exercise_price":3.24,"exercise_date":"2019-07-24","expiration_date":"2029-07-24","underlying":"Common Stock","underlying_shares":970},"source":{"system":"sec-edgar","filing":"0001104659-19-041843","document":"a4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1363763/000110465919041843/a4.xml","form_type":"4"}},{"id":3816481,"issuer":{"id":146118,"kind":"organization","name":"RespireRx Pharmaceuticals Inc.","symbol":"RSPI"},"owners":[{"id":139178,"kind":"person","name":"Lippa Arnold","position":1,"cik":"0001363763","reported_name":"Lippa Arnold","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Exec Chairman, CSO"}}],"security":"Common stock Warrants (right to buy)","published_at":"2018-09-14T17:56:11.000Z","date":"2018-09-12","kind":"gift","acquired":false,"shares":47620,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"Dr. Lippa gifted these securities into a family trust for estate planning purposes.  He is not the trustee and does not exercise voting control over shares held in the trust but he is a beneficiary of the trust."}],"balance_after":0,"derivative":{"exercise_price":1.575,"exercise_date":"2018-09-12","expiration_date":"2023-04-30","underlying":"Common Stock","underlying_shares":47620},"source":{"system":"sec-edgar","filing":"0001363763-18-000001","document":"primary_doc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/849636/000136376318000001/primary_doc.xml","form_type":"4"}},{"id":3816480,"issuer":{"id":146118,"kind":"organization","name":"RespireRx Pharmaceuticals Inc.","symbol":"RSPI"},"owners":[{"id":139178,"kind":"person","name":"Lippa Arnold","position":1,"cik":"0001363763","reported_name":"Lippa Arnold","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Exec Chairman, CSO"}}],"security":"Common Stock Warrants (right to buy)","published_at":"2018-09-14T17:56:11.000Z","date":"2018-09-12","kind":"purchase","acquired":true,"shares":47620,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"On April 5, 2018, the Company issued a promissory note to Dr. Lippa in the principal amount of $50,000.  On September 12, 2018, the Company redeemed the note, and Dr. Lippa used $50,000 in redemption proceeds to acquire 47,620 units, each unit comprising 47,620 shares of Common Stock and 47,620 Warrants, each Warrant representing the right to purchase an additional share of Common Stock."}],"balance_after":47620,"derivative":{"exercise_price":1.575,"exercise_date":"2018-09-12","expiration_date":"2023-04-30","underlying":"Common Stock","underlying_shares":47620},"source":{"system":"sec-edgar","filing":"0001363763-18-000001","document":"primary_doc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/849636/000136376318000001/primary_doc.xml","form_type":"4"}},{"id":3816479,"issuer":{"id":146118,"kind":"organization","name":"RespireRx Pharmaceuticals Inc.","symbol":"RSPI"},"owners":[{"id":139178,"kind":"person","name":"Lippa Arnold","position":1,"cik":"0001363763","reported_name":"Lippa Arnold","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Exec Chairman, CSO"}}],"security":"Common stock","published_at":"2018-09-14T17:56:11.000Z","date":"2018-09-12","kind":"gift","acquired":false,"shares":47620,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"Dr. Lippa gifted these securities into a family trust for estate planning purposes.  He is not the trustee and does not exercise voting control over shares held in the trust but he is a beneficiary of the trust."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001363763-18-000001","document":"primary_doc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/849636/000136376318000001/primary_doc.xml","form_type":"4"}},{"id":3816478,"issuer":{"id":146118,"kind":"organization","name":"RespireRx Pharmaceuticals Inc.","symbol":"RSPI"},"owners":[{"id":139178,"kind":"person","name":"Lippa Arnold","position":1,"cik":"0001363763","reported_name":"Lippa Arnold","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Exec Chairman, CSO"}}],"security":"Common Stock","published_at":"2018-09-14T17:56:11.000Z","date":"2018-09-12","kind":"purchase","acquired":true,"shares":47620,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"On April 5, 2018, the Company issued a promissory note to Dr. Lippa in the principal amount of $50,000.  On September 12, 2018, the Company redeemed the note, and Dr. Lippa used $50,000 in redemption proceeds to acquire 47,620 units, each unit comprising 47,620 shares of Common Stock and 47,620 Warrants, each Warrant representing the right to purchase an additional share of Common Stock."}],"balance_after":47620,"source":{"system":"sec-edgar","filing":"0001363763-18-000001","document":"primary_doc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/849636/000136376318000001/primary_doc.xml","form_type":"4"}},{"id":3874239,"issuer":{"id":8208,"kind":"organization","name":"Hepion Pharmaceuticals, Inc.","symbol":"HEPA"},"owners":[{"id":139178,"kind":"person","name":"Lippa Arnold","position":1,"cik":"0001363763","reported_name":"Lippa Arnold","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Warrants","published_at":"2018-07-03T14:16:58.000Z","date":"2018-07-03","kind":"purchase","acquired":true,"shares":8625,"price":1000,"value":8625000.0,"ownership":{"direct":false,"nature":"Linda Lippa Family Trust of 2007"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Shares of Series C Convertible Preferred Stock and Warrants were issued as part of a unit, with each unit consisting of one share of Series C Convertible Preferred Stock and 575 Warrants"}],"balance_after":8625,"derivative":{"exercise_price":1.55,"exercise_date":"2018-07-03","expiration_date":"2023-07-03","underlying":"Common Stock","underlying_shares":8625},"source":{"system":"sec-edgar","filing":"0001104659-18-043794","document":"a4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1363763/000110465918043794/a4.xml","form_type":"4"}},{"id":3874238,"issuer":{"id":8208,"kind":"organization","name":"Hepion Pharmaceuticals, Inc.","symbol":"HEPA"},"owners":[{"id":139178,"kind":"person","name":"Lippa Arnold","position":1,"cik":"0001363763","reported_name":"Lippa Arnold","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Series C Convertible Preferred Stock","published_at":"2018-07-03T14:16:58.000Z","date":"2018-07-03","kind":"purchase","acquired":true,"shares":15,"price":1000,"value":15000.0,"ownership":{"direct":false,"nature":"Linda Lippa Family Trust of 2007"},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each share of Series C Convertible Preferred Stock is convertible into the number of shares of Common Stock equal to the stated value of $1,000 divided by $1.55."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Shares of Series C Convertible Preferred Stock and Warrants were issued as part of a unit, with each unit consisting of one share of Series C Convertible Preferred Stock and 575 Warrants"},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"Shares of Series C Convertible Preferred Stock do not expire."}],"balance_after":15,"derivative":{"exercise_price":1.55,"exercise_date":"2018-07-03","underlying":"Common Stock","underlying_shares":9678},"source":{"system":"sec-edgar","filing":"0001104659-18-043794","document":"a4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1363763/000110465918043794/a4.xml","form_type":"4"}},{"id":4135618,"issuer":{"id":146118,"kind":"organization","name":"RespireRx Pharmaceuticals Inc.","symbol":"RSPI"},"owners":[{"id":139178,"kind":"person","name":"Lippa Arnold","position":1,"cik":"0001363763","reported_name":"Lippa Arnold","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Exec Chairman, CSO"}}],"security":"Common Stock Options (to purchase shares of Common Stock)","published_at":"2017-12-12T19:23:38.000Z","date":"2017-12-09","kind":"gift","acquired":false,"shares":559595,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"Dr. Lippa gifted these Common Stock Options into a family trust for estate planning purposes. He is not the trustee and does not exercise voting or investment control over shares held in the trust but he is a beneficiary of the trust."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"On December 9, 2017, Dr. Lippa forgave all of the accrued but unpaid compensation to which, pursuant to his employment agreement, he was entitled as of September 30, 2017, an aggregate of $807,497.  On that date, the Company granted to Dr. Lippa options to purchase 559,595 shares of the Company's common stock, with a black-scholes value of $1.44 per option and an aggregate value of $807,497.  These Common Stock Options vested upon issuance."}],"balance_after":0,"derivative":{"exercise_price":1.45,"expiration_date":"2022-12-09","underlying":"Commmon Stock","underlying_shares":559595},"source":{"system":"sec-edgar","filing":"0001573202-17-000011","document":"primary_doc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/849636/000157320217000011/primary_doc.xml","form_type":"4"}},{"id":4135617,"issuer":{"id":146118,"kind":"organization","name":"RespireRx Pharmaceuticals Inc.","symbol":"RSPI"},"owners":[{"id":139178,"kind":"person","name":"Lippa Arnold","position":1,"cik":"0001363763","reported_name":"Lippa Arnold","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Exec Chairman, CSO"}}],"security":"Common Stock Options (to purchase shares of Common Stock)","published_at":"2017-12-12T19:23:38.000Z","date":"2017-12-09","kind":"other","acquired":true,"shares":559595,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"On December 9, 2017, Dr. Lippa forgave all of the accrued but unpaid compensation to which, pursuant to his employment agreement, he was entitled as of September 30, 2017, an aggregate of $807,497.  On that date, the Company granted to Dr. Lippa options to purchase 559,595 shares of the Company's common stock, with a black-scholes value of $1.44 per option and an aggregate value of $807,497.  These Common Stock Options vested upon issuance."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"On December 9, 2017, Dr. Lippa forgave all of the accrued but unpaid compensation to which, pursuant to his employment agreement, he was entitled as of September 30, 2017, an aggregate of $807,497.  On that date, the Company granted to Dr. Lippa options to purchase 559,595 shares of the Company's common stock, with a black-scholes value of $1.44 per option and an aggregate value of $807,497.  These Common Stock Options vested upon issuance."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"On December 9, 2017, Dr. Lippa forgave all of the accrued but unpaid compensation to which, pursuant to his employment agreement, he was entitled as of September 30, 2017, an aggregate of $807,497.  On that date, the Company granted to Dr. Lippa options to purchase 559,595 shares of the Company's common stock, with a black-scholes value of $1.44 per option and an aggregate value of $807,497.  These Common Stock Options vested upon issuance."}],"balance_after":559595,"derivative":{"exercise_price":1.45,"expiration_date":"2022-12-09","underlying":"Commn Stock","underlying_shares":559595},"source":{"system":"sec-edgar","filing":"0001573202-17-000011","document":"primary_doc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/849636/000157320217000011/primary_doc.xml","form_type":"4"}},{"id":4266195,"issuer":{"id":146118,"kind":"organization","name":"RespireRx Pharmaceuticals Inc.","symbol":"RSPI"},"owners":[{"id":139178,"kind":"person","name":"Lippa Arnold","position":1,"cik":"0001363763","reported_name":"Lippa Arnold","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Executive Chairman & CSO"}}],"security":"Common Stock Options (to purchase shares of Common Stock)","published_at":"2017-07-05T20:45:57.000Z","date":"2017-06-30","kind":"other","acquired":false,"shares":50000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"Mr. Lippa transferred these Common Stock Options into a family trust for estate planning purposes. He is not the trustee and does not exercise voting or investment control over shares held in the trust but he is a beneficiary of the trust."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"These Common Stock Options vested upon issuance."}],"balance_after":0,"derivative":{"exercise_price":2,"expiration_date":"2022-06-30","underlying":"common stock","underlying_shares":50000},"source":{"system":"sec-edgar","filing":"0001573202-17-000004","document":"primary_doc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/849636/000157320217000004/primary_doc.xml","form_type":"4"}},{"id":4266194,"issuer":{"id":146118,"kind":"organization","name":"RespireRx Pharmaceuticals Inc.","symbol":"RSPI"},"owners":[{"id":139178,"kind":"person","name":"Lippa Arnold","position":1,"cik":"0001363763","reported_name":"Lippa Arnold","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Executive Chairman & CSO"}}],"security":"Common Stock Options (to purchase shares of Common Stock)","published_at":"2017-07-05T20:45:57.000Z","date":"2017-06-30","kind":"grant","acquired":true,"shares":50000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"These Common Stock Options vested upon issuance."}],"balance_after":50000,"derivative":{"exercise_price":2,"expiration_date":"2022-06-30","underlying":"common stock","underlying_shares":50000},"source":{"system":"sec-edgar","filing":"0001573202-17-000004","document":"primary_doc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/849636/000157320217000004/primary_doc.xml","form_type":"4"}},{"id":4485771,"issuer":{"id":146118,"kind":"organization","name":"RespireRx Pharmaceuticals Inc.","symbol":"RSPI"},"owners":[{"id":139178,"kind":"person","name":"Lippa Arnold","position":1,"cik":"0001363763","reported_name":"Lippa Arnold","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Executive Chairman and CSO"}}],"security":"Common Stock Options (to purchase shares of Common Stock)","published_at":"2017-01-20T21:16:35.000Z","date":"2017-01-18","kind":"other","acquired":false,"shares":50000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"Mr. Lippa transferred these Common Stock Options into a family trust for estate planning purposes. He is not the trustee and does not exercise voting or investment control over shares held in the trust but he is a beneficiary of the trust."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"These Common Stock Options vest in three installments:  25 percent on January 18, 2017 (the grant date), 25 percent on March 31, 2017, and 50 percent on June 30, 2017."}],"balance_after":0,"derivative":{"exercise_price":3.9,"expiration_date":"2017-01-18","underlying":"Common Stock","underlying_shares":50000},"source":{"system":"sec-edgar","filing":"0001363763-17-000004","document":"primary_doc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/849636/000136376317000004/primary_doc.xml","form_type":"4"}},{"id":4485770,"issuer":{"id":146118,"kind":"organization","name":"RespireRx Pharmaceuticals Inc.","symbol":"RSPI"},"owners":[{"id":139178,"kind":"person","name":"Lippa Arnold","position":1,"cik":"0001363763","reported_name":"Lippa Arnold","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Executive Chairman and CSO"}}],"security":"Common Stock Options (to purchase shares of Common Stock)","published_at":"2017-01-20T21:16:35.000Z","date":"2017-01-18","kind":"grant","acquired":true,"shares":50000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"These Common Stock Options vest in three installments:  25 percent on January 18, 2017 (the grant date), 25 percent on March 31, 2017, and 50 percent on June 30, 2017."}],"balance_after":50000,"derivative":{"exercise_price":3.9,"expiration_date":"2022-01-18","underlying":"Common Stock","underlying_shares":50000},"source":{"system":"sec-edgar","filing":"0001363763-17-000004","document":"primary_doc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/849636/000136376317000004/primary_doc.xml","form_type":"4"}}]}